filmov
tv
How Clinical Trials Transform Myeloma Care & Survival: Awareness, Trust & Access with Brian McMahon
Показать описание
Join IMF Chief Medical Officer Dr. Joseph Mikhael and SparkCures CEO Brian McMahon as they discuss the life-changing role of clinical trials in multiple myeloma care. Brian shares his personal journey as a care partner for his mother, a myeloma patient, and highlights the importance of raising awareness, building trust, and increasing access to clinical trials.
Discover how clinical trials not only advance treatment but also provide hope and extended time for patients and their families. Learn how the IMF and SparkCures are simplifying trial participation and revolutionizing care for myeloma patients everywhere.
Key Topics Covered
0:00 - Introduction
1:06 - Clinical trial awareness, trust, and access
3:00- How clinical trials extended life for Brian's mother.
6:20 - The evolution of multiple myeloma treatments and survival rates.
10:25 - Misconceptions about trials and their real-time benefits for patients.
12:45 - Addressing awareness, trust, and accessibility challenges.
16:25 - How the IMF and SparkCures improve patient access to trials.
18:47 - Tools for finding clinical trials and making informed decisions.
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Find us online:
Category
Nonprofits & Activism
License
Standard YouTube License
In most cases, captions are autogenerated by YouTube.
Discover how clinical trials not only advance treatment but also provide hope and extended time for patients and their families. Learn how the IMF and SparkCures are simplifying trial participation and revolutionizing care for myeloma patients everywhere.
Key Topics Covered
0:00 - Introduction
1:06 - Clinical trial awareness, trust, and access
3:00- How clinical trials extended life for Brian's mother.
6:20 - The evolution of multiple myeloma treatments and survival rates.
10:25 - Misconceptions about trials and their real-time benefits for patients.
12:45 - Addressing awareness, trust, and accessibility challenges.
16:25 - How the IMF and SparkCures improve patient access to trials.
18:47 - Tools for finding clinical trials and making informed decisions.
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Find us online:
Category
Nonprofits & Activism
License
Standard YouTube License
In most cases, captions are autogenerated by YouTube.
0:21:49
How Clinical Trials Transform Myeloma Care & Survival: Awareness, Trust & Access with Brian ...
0:59:53
Clinical Trials in Multiple Myeloma
0:12:02
Participating in a Multiple Myeloma Clinical Trial Part 1: Your Questions Answered
0:33:11
Understanding Clinical Trials
0:23:28
Richter’s syndrome: What are the options?
1:13:49
The Latest in Multiple Myeloma Treatments: What Clinical Trials are Available to Me?
0:01:15
From clinical trials to clinical practice: Upcoming drug developments in multiple myeloma
1:15:00
The Importance of Clinical Trials with Dr. Craig Cole
0:02:01
Dr. Joshua Richter Discusses Multiple Myeloma Clinical Trials
0:08:49
Participating in a Multiple Myeloma Clinical Trial Part 2: Debunking Myths & Fears
0:57:04
Myeloma Matters Podcast | Clinical Studies
0:26:51
Richter’s Syndrome: Risk, predictors, and treatment
0:05:28
Recent Clinical Trials for Newly-Diagnosed Multiple Myeloma, with Dr. Raj Chakraborty
0:56:03
FAQs on Understanding Clinical Trials in Multiple Myeloma
0:13:21
Clinical Trial Enrollment Challenges in Multiple Myeloma (IMPACT Audio Lessons)
0:24:22
Highlight of CLL-related 2016 FDA approvals: Venetoclax
0:32:08
Introducing PACT Patient Centered Approach to Clinical Trials
0:04:58
Novel immunotherapies transforming R/R myeloma treatment: bispecifics, CAR-T cells & more
0:15:50
Biomarkers and patient eligibility for CAR T cell therapies in DLBCL
0:02:22
Clinical Trial: INSIGHT Trial by Takeda Oncology
0:01:48
The growing importance of monoclonal antibodies in transplant-eligible & ineligible myeloma
0:27:42
M-Power NY | Drs. Joseph Mikhael and Saad Usmani On Clinical Trials: Why Would I Participate?
0:04:15
What are IMiDs and how do they work?
0:02:51
Clinical Trial: bb2121 CAR T Therapy, Larry Anderson, MD
Комментарии